Effects of Tibetan medicine Longdan zhike tablet on chronic obstructive pulmonary disease through MAPK pathway

慢性阻塞性肺病 医学 药理学 慢性支气管炎 传统医学 中医药 支气管炎 呼吸系统 替代医学 内科学 病理
作者
Yulin Feng,Pengfei Qin,Rong Wang,Yahui Mi,You Li,Jiahao Feng,Wen-Bin Shen,Haijuan Dong,Jietai Duo,Liming Ma,Xiaowu Yao,Xiaolong Hu,Fei Xiong,Xinhong Shi,Hao Wang
出处
期刊:Journal of Ethnopharmacology [Elsevier BV]
卷期号:328: 118082-118082
标识
DOI:10.1016/j.jep.2024.118082
摘要

Longdan zhike tablet (LDZK) is a Tibetan medicine formula commonly used in the highland region of Tibet, China, to ameliorate respiratory diseases, such as acute bronchitis and asthma. In Chinese traditional medicine, some herbal formulas with anti-inflammatory properties targeting the respiratory system are clinically adopted as supplementary therapies for chronic obstructive pulmonary disease (COPD). However, the specific anti-COPD effects of LDZK remain to be evaluated. The aim of this study is to identify the principal bioactive compounds in LDZK, and elucidate the effects and mechanisms of the LDZK on COPD. High-resolution mass spectrometry was utilized for a comprehensive characterization of the chemical composition of LDZK. The therapeutic effects of LDZK were assessed on the LPS-papain-induced COPD mouse model, and LPS-induced activation model of A549 cells. The safety of LDZK was evaluated by orally administering a single dose of 30 g/kg to rats and monitoring physiological and biochemical indicators after a 14-day period. Network pharmacology and Western blot analysis were employed for mechanism prediction of LDZK. A comprehensive analysis identified a total of 45 compounds as the major constituents of LDZK. Oral administration of LDZK resulted in notable ameliorative effects in respiratory function, accompanied by reduced inflammatory cell counts and cytokine levels in the lungs of COPD mice. Acute toxicity tests demonstrated a favorable safety profile at a dose equivalent to 292 times the clinically prescribed dose. In vitro studies revealed that LDZK exhibited protective effects on A549 cells by mitigating LPS-induced cellular damage, reducing the release of NO, and downregulating the expression of iNOS, COX2, IL-1β, IL-6, and TNF-α. Network pharmacology and Western blot analysis indicated that LDZK primarily modulated the MAPK signaling pathway and inhibited the phosphorylation of p38/ERK/JNK. LDZK exerts significant therapeutic effects on COPD through the regulation of the MAPK pathway, suggesting its potential as a promising adjunctive therapy for the treatment of chronic inflammation in COPD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
科研菜鸟发布了新的文献求助10
1秒前
lalala发布了新的文献求助10
1秒前
zzaxx123发布了新的文献求助10
3秒前
星辰大海应助mm采纳,获得10
3秒前
蜜雪冰城完成签到,获得积分10
3秒前
3秒前
3秒前
tetrisxzs发布了新的文献求助10
4秒前
leonork发布了新的文献求助10
4秒前
香蕉觅云应助like1994采纳,获得10
4秒前
wang完成签到 ,获得积分10
6秒前
nn发布了新的文献求助10
6秒前
Wwt发布了新的文献求助10
6秒前
jacinth完成签到,获得积分10
7秒前
研友_VZG7GZ应助Cici采纳,获得10
7秒前
MHX关闭了MHX文献求助
8秒前
华仔应助漂亮采波采纳,获得10
8秒前
馒头应助漂亮采波采纳,获得10
8秒前
乐乐应助漂亮采波采纳,获得10
8秒前
科研通AI2S应助漂亮采波采纳,获得10
8秒前
8秒前
科目三应助今夜小楼一曲采纳,获得10
9秒前
情怀应助Ted采纳,获得10
9秒前
9秒前
9秒前
10秒前
10秒前
木子完成签到,获得积分10
10秒前
10秒前
PsyQin完成签到,获得积分10
11秒前
511发布了新的文献求助10
11秒前
慕青应助科研菜鸟采纳,获得30
11秒前
狂野怜蕾发布了新的文献求助10
12秒前
晚风发布了新的文献求助30
12秒前
所所应助羊羊羊采纳,获得10
13秒前
leonork完成签到,获得积分10
13秒前
柒柒的小熊完成签到,获得积分10
13秒前
聪明凌柏发布了新的文献求助10
14秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3971078
求助须知:如何正确求助?哪些是违规求助? 3515742
关于积分的说明 11179305
捐赠科研通 3250852
什么是DOI,文献DOI怎么找? 1795501
邀请新用户注册赠送积分活动 875868
科研通“疑难数据库(出版商)”最低求助积分说明 805207